Cephalon Sues Barr Again Over Generic Fentora ANDA
Faced with continued efforts to bring a generic version of Fentora to market, Cephalon Inc. last week filed a second suit against Barr Pharmaceuticals Inc., three months after suing Barr to...To view the full article, register now.
Already a subscriber? Click here to view full article